PE20060144A1 - Composiciones farmaceuticas que comprenden risedronato - Google Patents
Composiciones farmaceuticas que comprenden risedronatoInfo
- Publication number
- PE20060144A1 PE20060144A1 PE2004000960A PE2004000960A PE20060144A1 PE 20060144 A1 PE20060144 A1 PE 20060144A1 PE 2004000960 A PE2004000960 A PE 2004000960A PE 2004000960 A PE2004000960 A PE 2004000960A PE 20060144 A1 PE20060144 A1 PE 20060144A1
- Authority
- PE
- Peru
- Prior art keywords
- pharmaceutical compositions
- compositions including
- risedronate
- presents
- additional equipment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE CON PREFERENCIA 150, 75 O 50 MG DE RISEDRONATO EN UNA, DOS O TRES DOSIS UNITARIAS RESPECTIVAMENTE BAJO LA FORMA DE TABLETAS QUE COMPRENDEN UNA PELICULA RECUBRIDORA LAS CUALES FORMAN UN EQUIPO QUE ADEMAS PRESENTA UNA DOSIS UNITARIA ADICIONAL QUE CONSTA DE UN NUTRIENTE TAL COMO CALCIO, VIT. D O UNA COMBINACION DE AMBOS. DICHA COMPOSICION ES USADA PARA TRATAR O PREVENIR LA OSTEOPOROSIS Y OTROS TRASTORNOS METABOLICOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/897,897 US20050070504A1 (en) | 2001-12-21 | 2004-07-23 | Risedronate compositions and their methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20060144A1 true PE20060144A1 (es) | 2006-04-17 |
Family
ID=34958880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2004000960A PE20060144A1 (es) | 2004-07-23 | 2004-09-30 | Composiciones farmaceuticas que comprenden risedronato |
Country Status (20)
Country | Link |
---|---|
US (1) | US20050070504A1 (es) |
EP (1) | EP1776123A1 (es) |
JP (3) | JP5377852B2 (es) |
KR (2) | KR20070038115A (es) |
CN (1) | CN101146542A (es) |
AR (1) | AR046036A1 (es) |
AU (2) | AU2004322703B2 (es) |
BR (1) | BRPI0418973A (es) |
CA (1) | CA2564898A1 (es) |
IL (1) | IL180907A0 (es) |
IS (1) | IS8597A (es) |
MA (1) | MA28778B1 (es) |
MX (1) | MX2007000967A (es) |
NO (1) | NO20071058L (es) |
NZ (1) | NZ552799A (es) |
PE (1) | PE20060144A1 (es) |
RU (1) | RU2007103306A (es) |
TW (1) | TWI351286B (es) |
WO (1) | WO2006022755A1 (es) |
ZA (1) | ZA200701308B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI349553B (en) * | 2001-12-21 | 2011-10-01 | Procter & Gamble | Kit and use of bisphosphonate for treating high bone turnover |
MXPA04009586A (es) * | 2002-05-10 | 2005-01-11 | Hoffmann La Roche | Acidos bisfosfonicos para el tratamiento y prevencion de la osteoporosis. |
SI1596870T2 (sl) * | 2002-12-20 | 2011-07-29 | Hoffmann La Roche | Formulacija z visokim odmerkom ibandronata |
US20080286359A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
US20080287400A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
AU2011218625B2 (en) * | 2004-05-24 | 2014-03-20 | Theramex HQ UK Limited | Dosage forms of risedronate |
US7645459B2 (en) | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
US8071574B2 (en) * | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
US7473684B2 (en) | 2005-09-16 | 2009-01-06 | Selamine Limited | Bisphosphonate formulation |
EP1945185B1 (en) * | 2005-10-12 | 2016-02-03 | Proventiv Therapeutics, LLC | Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
KR100844256B1 (ko) | 2007-03-23 | 2008-07-07 | 코오롱제약주식회사 | 리세드로네이트와 비타민 d를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법 |
WO2010014765A1 (en) * | 2008-07-31 | 2010-02-04 | Warner Chilcott Company, Llc | Low dosage forms of risedronate or its salts |
KR101379664B1 (ko) * | 2008-09-23 | 2014-04-02 | 한림제약(주) | 리세드론산 또는 그의 염 및 비타민 d를 포함하는 약학 조성물 |
KR101102364B1 (ko) | 2009-09-18 | 2012-01-03 | 한림제약(주) | 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물 |
PT106978A (pt) * | 2013-05-31 | 2014-12-02 | Tecnimede Sociedade Tecnico Medicinal S A | Composição sólida oral contendo ácido ibandrónico e vitamina d |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA777769A (en) * | 1963-03-18 | 1968-02-06 | H. Roy Clarence | Substituted methylene diphosphonic acid compounds and detergent compositions |
IT1201087B (it) * | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
FR2531088B1 (fr) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
CA1339805C (en) * | 1988-01-20 | 1998-04-07 | Yasuo Isomura | (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active |
CA1336328C (en) * | 1988-04-11 | 1995-07-18 | Walter G. Leonard | Method of increasing bone density in humans |
US4922007A (en) * | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
US5227506A (en) * | 1989-09-06 | 1993-07-13 | Merck & Co., Inc. | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors |
NL8902727A (nl) * | 1989-11-06 | 1991-06-03 | Philips Nv | Objecthouder voor ondersteuning van een object in een geladen deeltjesbundelsysteem. |
CA2138366C (en) * | 1992-06-30 | 1998-09-22 | Kristine Hovancik | Methods for the treatment of arthritis using phosphonates and nsaids |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
US6008206A (en) * | 1994-09-21 | 1999-12-28 | Merck & Co., Inc. | Sodium alendronate preparation for local administration |
US6750216B2 (en) * | 1996-03-08 | 2004-06-15 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US5730715A (en) * | 1996-06-14 | 1998-03-24 | Becton Dickinson And Company | Method for the iontophoretic administration of bisphosphonates |
GB2324726A (en) * | 1997-05-01 | 1998-11-04 | Merck & Co Inc | Combination Therapy for the Treatment of Osteoporosis |
KR100400053B1 (ko) * | 1997-06-11 | 2003-09-29 | 더 프록터 앤드 갬블 캄파니 | 향상된 상부 위장관 안전용 필름 피복 정제 |
US6432932B1 (en) * | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6015801A (en) * | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6331533B1 (en) * | 1998-11-16 | 2001-12-18 | Merck & Co., Inc. | Method for inhibiting dental resorptive lesions |
US6225801B1 (en) * | 1999-01-14 | 2001-05-01 | Lucent Technologies Inc. | Article comprising electronic circuits and devices with magnetically programmable electrical resistance |
JP2001253827A (ja) * | 2000-02-15 | 2001-09-18 | Pfizer Prod Inc | 骨粗鬆症を治療するための組成物および方法 |
US6468559B1 (en) * | 2000-04-28 | 2002-10-22 | Lipocine, Inc. | Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods |
EP1296689B3 (en) * | 2000-06-20 | 2013-02-13 | Novartis AG | Method of administering bisphosphonates |
US6593310B1 (en) * | 2000-11-21 | 2003-07-15 | Arthropharm Pty. Ltd. | Treatment of osteoporosis |
JP2005516928A (ja) * | 2001-12-13 | 2005-06-09 | メルク エンド カムパニー インコーポレーテッド | 骨異常のためのビスホスホネート液体製剤 |
MXPA04009586A (es) * | 2002-05-10 | 2005-01-11 | Hoffmann La Roche | Acidos bisfosfonicos para el tratamiento y prevencion de la osteoporosis. |
US20040188316A1 (en) * | 2003-03-26 | 2004-09-30 | The Procter & Gamble Company | Kit for pharmaceutical use |
-
2004
- 2004-07-23 US US10/897,897 patent/US20050070504A1/en not_active Abandoned
- 2004-09-25 KR KR1020077001602A patent/KR20070038115A/ko not_active Application Discontinuation
- 2004-09-25 BR BRPI0418973-6A patent/BRPI0418973A/pt not_active Application Discontinuation
- 2004-09-25 JP JP2007522476A patent/JP5377852B2/ja active Active
- 2004-09-25 CA CA002564898A patent/CA2564898A1/en not_active Abandoned
- 2004-09-25 AU AU2004322703A patent/AU2004322703B2/en not_active Withdrawn - After Issue
- 2004-09-25 MX MX2007000967A patent/MX2007000967A/es unknown
- 2004-09-25 EP EP04789250A patent/EP1776123A1/en not_active Ceased
- 2004-09-25 KR KR1020087021196A patent/KR20080083219A/ko active Search and Examination
- 2004-09-25 RU RU2007103306/14A patent/RU2007103306A/ru unknown
- 2004-09-25 CN CNA2004800436570A patent/CN101146542A/zh active Pending
- 2004-09-25 WO PCT/US2004/031975 patent/WO2006022755A1/en active Application Filing
- 2004-09-25 NZ NZ552799A patent/NZ552799A/en not_active IP Right Cessation
- 2004-09-29 AR ARP040103537A patent/AR046036A1/es unknown
- 2004-09-30 PE PE2004000960A patent/PE20060144A1/es not_active Application Discontinuation
- 2004-11-30 TW TW093136901A patent/TWI351286B/zh not_active IP Right Cessation
-
2007
- 2007-01-23 IL IL180907A patent/IL180907A0/en unknown
- 2007-01-24 IS IS8597A patent/IS8597A/is unknown
- 2007-02-01 MA MA29645A patent/MA28778B1/fr unknown
- 2007-02-14 ZA ZA200701308A patent/ZA200701308B/en unknown
- 2007-02-22 NO NO20071058A patent/NO20071058L/no not_active Application Discontinuation
-
2011
- 2011-03-02 AU AU2011200905A patent/AU2011200905A1/en not_active Abandoned
-
2013
- 2013-08-16 JP JP2013169220A patent/JP5761274B2/ja active Active
-
2014
- 2014-10-21 JP JP2014214604A patent/JP5910698B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
ZA200701308B (en) | 2008-07-30 |
KR20070038115A (ko) | 2007-04-09 |
AU2011200905A1 (en) | 2011-03-24 |
MA28778B1 (fr) | 2007-08-01 |
EP1776123A1 (en) | 2007-04-25 |
US20050070504A1 (en) | 2005-03-31 |
NO20071058L (no) | 2007-02-22 |
JP2015038135A (ja) | 2015-02-26 |
IS8597A (is) | 2007-01-24 |
JP2013231087A (ja) | 2013-11-14 |
MX2007000967A (es) | 2007-07-11 |
AU2004322703A1 (en) | 2006-03-02 |
JP5910698B2 (ja) | 2016-04-27 |
KR20080083219A (ko) | 2008-09-16 |
BRPI0418973A (pt) | 2007-12-04 |
IL180907A0 (en) | 2007-07-04 |
TWI351286B (en) | 2011-11-01 |
CA2564898A1 (en) | 2006-03-02 |
AU2004322703B2 (en) | 2010-12-02 |
NZ552799A (en) | 2010-04-30 |
AR046036A1 (es) | 2005-11-23 |
CN101146542A (zh) | 2008-03-19 |
JP2008507513A (ja) | 2008-03-13 |
JP5377852B2 (ja) | 2013-12-25 |
RU2007103306A (ru) | 2008-09-10 |
JP5761274B2 (ja) | 2015-08-12 |
WO2006022755A1 (en) | 2006-03-02 |
TW200603816A (en) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20060144A1 (es) | Composiciones farmaceuticas que comprenden risedronato | |
GT200300075BA (es) | Compuestos que modulan la actividad ppar y procedimientos para su preparacion (patente fraccionaria no. 2 de la solicitud no. pi-20030075) | |
HN2005000255A (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis | |
GT200600028A (es) | Compuestos y composiciones como inhibidores de proteina kinasa | |
BR112018010018A2 (pt) | moduladores de ror-gama | |
CL2008003284A1 (es) | Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras. | |
BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
HN2009001112A (es) | Inhibidores de la actividad de la akt | |
CR10566A (es) | Compuestos heterociclicos adecuados para el tratamiento de enfermedades relacionadas con nivel elevado de lipidos | |
UY28735A1 (es) | Derivados de indazol como inhibidores de la lipasa sensible a hormonas | |
NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
CO5190672A1 (es) | Composicion para la dosificacion oral, de disolucion instantanea | |
MA31433B1 (fr) | Inhibiteurs de la p70 s6 kinase | |
AR058780A1 (es) | Imidazopirazinas como inhibidores de quinasas dependientes de ciclina | |
MA30725B1 (fr) | Administration d'inhibiteurs de la dipeptidyl peptidase | |
DK1768748T3 (da) | Sammensætninger omfattende strontium og vitamin D samt anvendelser deraf | |
GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
UY27350A1 (es) | Azaindoles | |
NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
AR063098A1 (es) | Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina | |
AR079208A2 (es) | Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica | |
BR112013009153A2 (pt) | formulação de ligante de fosfato para dosagem única. | |
AR070026A1 (es) | Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus | |
BRPI0615989B8 (pt) | formulação farmacêutica de dosagem oral | |
MA29278B1 (fr) | Composition pharmaceutique comprenant un derive de l'indolylmaleimide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |